Tenax Therapeutics, Inc. Share Price & Technical Analysis
TENX · $12.23 (+0.82%)
Healthcare / Biotechnology
$12.23
+0.82%
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imati…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-8% return in May, 3% avg return in past 3 year May month.
8% return in 2026, -25% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 2% | -2% | 34% | -18% | -8% | – | – | – | – | – | – | – | 8% |
| 25 | -5% | 3% | 12% | -9% | 7% | -8% | 7% | -5% | 29% | -1% | 27% | 31% | 88% |
| 24 | -41% | -63% | -9% | -7% | -8% | -14% | 13% | 18% | -12% | 26% | 23% | 15% | -60% |
| 23 | -6% | -66% | -31% | -27% | 11% | -14% | 6% | 10% | -18% | -38% | 91% | -21% | -103% |
| 22 | -37% | -13% | 35% | -11% | -10% | -48% | -17% | -14% | -30% | -28% | 12% | -23% | -183% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Neutral
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$301.96M
P/E ratio
—
52W high
$18.38
52W low
$5.34
Volume
1,32,891
Beta
1.00
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Tenax Therapeutics, Inc. share price today?
- Tenax Therapeutics, Inc. (TENX) last traded around $12.23 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TENX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TENX. Download the app for real-time alerts.
- How can I analyze Tenax Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.